Assistive Device Training in Multiple Sclerosis (ADT)
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program.
The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Oregon
-
Portland, Oregon, Forente stater, 97239
- VA Portland Health Care System
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Multiple Sclerosis of any type,
- self-reported history of at least 1 fall in the previous year,
- able to walk at least 25 feet with or without an assistive device,
- clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment),
- intermittent or constant unilateral or bilateral assistance required to walk,
- right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study.
Exclusion Criteria:
- serious psychiatric or medical conditions that would preclude reliable participation in the study,
- dementia (MMSE <24),
- deafness,
- blindness,
- inability to follow directions in English,
- significant upper extremity tremor or weakness,
- more than 1 hour of assistive device training within the previous 3 years,
- any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Aktiv komparator: Training group
Subjects randomized to this group will receive a 6 week Assistive Device Training program in the use of their assistive device.
They will have mobility assessments taken at baseline, after the training program has been completed, and 3 months later.
During this time, their falls will be recorded monthly using prospective falls calendars.
Members of this group will also receive MRI scans at baseline and after the completion of the training program.
|
Six-week training program on the proper use of the subject's assistive device (eg.
cane, walker, etc).
|
|
Ingen inngripen: Wait-list control
Subjects in this group will participate in the same mobility assessments and completion of the falls calendars, but will receive no intervention during this time.
These subjects will have the opportunity to receive the training sessions when all assessment visits have been completed.
These subjects will not receive MRI scans.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Functional Mobility at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
|
Timed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Falls at Completion of Training and the Following Three Months
Tidsramme: First week of training, last week of training, 3 months later
|
Change in rate of falls between time frames
|
First week of training, last week of training, 3 months later
|
|
Change from Baseline in Functional Neural Connectivity (fMRI) at Completion of Training
Tidsramme: At baseline, 1 week after completion of training
|
Resting-state (task free) functional Magnetic Resonance Imaging (fcMRI)
|
At baseline, 1 week after completion of training
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Satisfaction with Assistive Device at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
|
Quebec User Evaluation of Satisfaction with Assistive Technologies
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Balance Confidence at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
|
Activities-specific Balance Confidence Questionnaire
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Multiple Sclerosis Impact at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
|
Multiple Sclerosis Impact Scale-29
|
At baseline, 1 week after completion of training, 3 months later
|
|
Change from Baseline in Physical Activity at Completion of Training and the Following Three Months
Tidsramme: At baseline, 1 week after completion of training, 3 months later
|
International Physical Activity Questionnaire
|
At baseline, 1 week after completion of training, 3 months later
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Samarbeidspartnere
Samarbeidspartnere
Etterforskere
Etterforskere
- Hovedetterforsker: Michelle H. Cameron, MD, PT MCR, Portland VA Medical Center
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 3559
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .